Augere Medical AS
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Augere Medical AS - overview
Established
2018
Location
Oslo, -, Norway
Primary Industry
Medical Devices & Equipment
About
Founded in 2018 by founder Pia Smedsrud, and based in Norway, Augere Medical AS develops a medical imaging platform designed to assist doctors in the early detection of colorectal cancer. In November 2024, Augere Medical raised USD 2. 1 million in venture funding. Augere Medical offers medical technology.
PolypAid is an advanced colonoscopy guidance system that employs artificial intelligence and video analytics to assist endoscopists in identifying adenomas, sessile serrated lesions, and hyperplastic polyps. The system processes images in real-time throughout the examination, thereby minimising the risk of human error and improving detection rates. The company will use the November 2024 funding to support the expansion of the PolypAID system in the European market and to enhance the company’s AI development capabilities.
Current Investors
MP Pensjon, Simula Innovation, Farvatn Venture
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment, Monitoring Equipment, Analytics & Performance Software
Website
www.augere.md/
Verticals
Artificial Intelligence, Manufacturing
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.